Compare AbCellera Biologics Inc (ABCL) vs Manhattan Associates Inc (MANH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Manhattan Associates Inc — how do they compare? AbCellera Biologics Inc trades at $9.05 (market cap $2.99B), while Manhattan Associates Inc trades at $190.49 (market cap $11.38B). The key difference: Manhattan Associates Inc is far larger — about 3.8× AbCellera Biologics Inc's market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, Manhattan Associates Inc nearer its low. Which is the better fit depends on your goals.
| ABCL | MANH | |
|---|---|---|
Market Cap | $2.99B | $11.38B |
Sector | Health | Technology |
52-Week High | $9.76 | $220.19 |
52-Week Low | $2.78 | $120.88 |
Enterprise Value | $2.58B | $11.25B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Manhattan Associates Inc
Manhattan Associates, Inc. is a global leader in supply chain and omnichannel commerce software. The company provides a comprehensive suite of cloud-based and on-premise solutions for warehouse management (WMS), transportation management (TMS), and order management (OMS). MANH's technology helps retailers, wholesalers, and manufacturers manage inventory, optimize logistics, and unify the shopping experience across physical and digital channels.
Read more on MANH →
